Menu
← Oncology Approval Tracker
FDA DECISION ·
Ogsiveo
nirogacestat · SpringWorks Therapeutics
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
For adults with progressing desmoid tumors that require systemic therapy.
LAMPGEN ANALYSIS
Why it matters
FDA approved the first treatment specifically for desmoid tumors, a rare locally aggressive tumor.
What research teams should watch
Verify documented progression and the need for systemic treatment. Build symptom and treatment-toxicity assessments into follow-up.
PRIMARY RECORDS